Shen Sicheng, Feng Huayi, Wang Chuyue, Yang Yingqi, Chen Zhiyang, Wang Xiaopeng, Li Jiacheng
Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, China.
BMC Gastroenterol. 2025 May 30;25(1):419. doi: 10.1186/s12876-025-04021-8.
The Dietary Index of Gut Microbiota (DI-GM) is a newly developed measure for assessing diet quality in relation to the diversity of the gut microbiome. However, whether it is associated with the risk of chronic constipation and chronic diarrhea remains unclear.
We analyzed data from 7,943 U.S. adults aged 20 years and older who participated in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). Weighted logistic regression, subgroup analysis, and restricted cubic spline (RCS) models were used to assess the association between the DI-GM and abnormal bowel symptoms.
A higher DI-GM score was significantly associated with a reduced risk of abnormal bowel symptoms. For each 1-point increase in the DI-GM, the risk of constipation decreased by 12.4% (OR = 0.876, 95% CI = 0.806-0.951, p = 0.002), and the risk of diarrhea decreased by 14.1% (OR = 0.859, 95% CI = 0.789-0.936, p < 0.001). Compared with the lowest DI-GM quartile, the highest quartile showed a markedly lower risk of both constipation (OR = 0.487, 95% CI = 0.340-0.696, p < 0.001) and diarrhea (OR = 0.480, 95% CI = 0.338-0.682, p < 0.001). RCS analysis indicated a significant linear association between the DI-GM and the risks of both constipation (nonlinear p = 0.686) and diarrhea (nonlinear p = 0.136).
The DI-GM was negatively associated with the prevalence of abnormal bowel symptoms. Further longitudinal studies are warranted to confirm these findings and to inform dietary strategies for gut health.
肠道微生物群饮食指数(DI-GM)是一种新开发的用于评估与肠道微生物群多样性相关的饮食质量的指标。然而,它是否与慢性便秘和慢性腹泻的风险相关仍不清楚。
我们分析了7943名年龄在20岁及以上的美国成年人的数据,这些人参与了2007 - 2010年国家健康和营养检查调查(NHANES)。采用加权逻辑回归、亚组分析和受限立方样条(RCS)模型来评估DI-GM与肠道异常症状之间的关联。
较高的DI-GM得分与肠道异常症状风险降低显著相关。DI-GM每增加1分,便秘风险降低12.4%(OR = 0.876,95%CI = 0.806 - 0.951,p = 0.002),腹泻风险降低14.1%(OR = 0.859,95%CI = 0.789 - 0.936,p < 0.001)。与最低DI-GM四分位数相比,最高四分位数的便秘(OR = 0.487,95%CI = 0.340 - 0.696,p < 0.001)和腹泻(OR = 0.480,95%CI = 0.338 - 0.682,p < 0.001)风险均显著降低。RCS分析表明DI-GM与便秘(非线性p = 0.686)和腹泻(非线性p = 0.136)风险之间存在显著的线性关联。
DI-GM与肠道异常症状的患病率呈负相关。有必要进行进一步的纵向研究以证实这些发现,并为肠道健康的饮食策略提供依据。